|4Jun 17, 9:40 PM ET

Dorton Stephen M 4

4 · Enfusion, Inc. · Filed Jun 17, 2022

Insider Transaction Report

Form 4
Period: 2022-06-15
Dorton Stephen M
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-06-15+16,00016,000 total
    Exercise: $9.86Exp: 2032-06-15Class A Common Stock (16,000 underlying)
  • Award

    Class A Common Stock

    2022-06-15+10,142186,613 total
Footnotes (2)
  • [F1]Consist of restricted stock units ("RSUs") awarded pursuant to the Enfusion, Inc. 2021 Stock Option and Incentive Plan (the "Plan"). The restricted stock units will vest in full as follows: 3,381, 3,381 and 3,380 restricted stock units will vest on June 15, 2023, June 15, 2024 and June 15, 2025, respectively.
  • [F2]These options were granted under the Plan and shall become exercisable as follows: 5,334, 5,333 and 5,333 on June 15, 2023, June 15, 2024 and June 15, 2025, respectively.

Documents

1 file
  • 4
    tm2218834-5_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT